Drug Executive Collapses During Oval Office Press Conference
During a press conference in the Oval Office, a drug executive fainted as President Donald Trump announced a deal with pharmaceutical companies to reduce prices on obesity drugs. The event was abruptly cut short.
Details of the Incident
The incident occurred while Trump and representatives from Eli Lilly and Novo Nordisk were discussing a new agreement aimed at expanding coverage and lowering costs for treatments like Zepbound and Wegovy. David Ricks, CEO of Eli Lilly, noticed the executive's distress and asked,
"Are you OK? Gordon, are you OK?"
Response and Identification
The man who collapsed was identified by Getty Images as Gordon Findlay, the global brand director for Novo Nordisk. Dr. Mehmet Oz, Administrator of the Centers for Medicare & Medicaid Services, quickly intervened as Findlay fell to his knees and lost consciousness. Afterward, the press was escorted out of the room.
Notable Attendees
- President Donald Trump
- David Ricks, CEO of Eli Lilly
- Gordon Findlay, Global Brand Director at Novo Nordisk
- Dr. Mehmet Oz, Administrator of the Centers for Medicare & Medicaid Services
- Health and Human Services Secretary
The presence of key leaders underlined the importance of the price reduction deal, despite the unforeseen medical emergency.
Author's Summary
This incident highlights the high-pressure environment around critical healthcare negotiations and the swift response of officials during unexpected emergencies.